50 results
Page 2 of 3
8-K
EX-99.1
4awkrm sm11
30 Jan 20
Lilly Reports Strong Fourth-Quarter and Full-Year 2019 Financial Results, Updates 2020 Guidance for Pending Dermira Acquisition
6:29am
SC TO-C
EX-99.1
l527t04
10 Jan 20
Information about tender offer
6:56am
8-K
EX-99.1
f9yaua105tf 5pftffn
17 Dec 19
Lilly Announces 2020 Financial Guidance, Updates 2019 Guidance
8:46am
8-K
EX-99.1
vg8khwe79cp07
23 Oct 19
Lilly Reports Strong Third-Quarter 2019 Financial Results, Raises 2019 EPS Guidance
7:28am
8-K
EX-99.2
6uytbrgang1xo0a
23 Oct 19
Lilly Reports Strong Third-Quarter 2019 Financial Results, Raises 2019 EPS Guidance
7:28am
8-K
EX-99.1
fi17d9ad7vlpk 79
30 Jul 19
Lilly Reports Second-Quarter 2019 Financial Results, Raises 2019 EPS Guidance
11:27am
8-K
EX-99.1
21ww9f89qshuiswrgt9
11 Jul 19
Departure of Directors or Certain Officers
10:58am
8-K
EX-99.1
0fwu7bdl50ux3s98ds4j
30 Apr 19
Lilly Reports Solid First-Quarter 2019 Financial Results, Updates 2019 Guidance to Reflect Disposition of Elanco Animal Health
1:31pm
425
9j5natnfa
13 Mar 19
Business combination disclosure
9:15am
425
clnt8lo7umcfynldmy3
11 Mar 19
Business combination disclosure
7:15am
425
w1mbvjl81
7 Mar 19
Business combination disclosure
8:16am
SC TO-T/A
EX-99
lft1cq
15 Feb 19
Third party tender offer statement (amended)
9:20am
425
q4mdguj
8 Feb 19
Business combination disclosure
10:39am
425
os4l0js3
8 Feb 19
Business combination disclosure
8:16am
8-K
EX-99.1
5tiy70cnebp
6 Feb 19
Results of Operations and Financial Condition
9:48am
SC TO-T/A
EX-99
xwtqu
1 Feb 19
Third party tender offer statement (amended)
7:16am
8-K
EX-99.1
khrllu9jau81uhmzua
7 Jan 19
Entry into a Material Definitive Agreement
3:01pm
SC TO-C
EX-99.1
6hw2jb
7 Jan 19
Information about tender offer
2:59pm
8-K
EX-99.1
9fzsly
19 Dec 18
Results of Operations and Financial Condition
1:04pm
8-K
EX-99.1
eaiazy33rb8efef6a515
6 Nov 18
Lilly Delivers Solid Third-Quarter 2018 Results, Revises EPS Guidance
7:03am